Figure 7.

Proximity biotinylation captures the proteins near Foxp3. (A) Schematic of the PSI of Foxp3 by proximity ligation via biotin-phenoxyl radicals. 1° Ab, primary antibody; 2° Ab, secondary antibodies; BP, biotin-phenol; HRP, horseradish peroxidase; SA, streptavidin. (B) Assessment of the specificity of Foxp3 PSI with Th0 and iTreg cells. CD4 Tn cells from Foxp3gfp mice were used to generate Th0 or iTreg cells. After PSI reaction, cells were stained with SA-AlexaFluor-568. Numbers show median fluorescence intensities (MFIs) of GFP or SA in Th0 and iTreg cells. Th0 cells, CD4 Tn cells activated by TCR agonists and IL-2 in vitro. (C) Immunofluorescence images of Treg cells from Foxp3gfp mice treated with Foxp3-PSI and subsequently stained for SA-AlexaFluor-568, GFP-booster-FITC, and Lamin-AlexaFluor-647. (D) 37,333 accessible regions (ATAC-seq) in Treg cells are cross-compared with Foxp3 PSI-ChIP, traditional (tra) Foxp3-, H3K27ac-, H3K4me3-, and H3K27me3-ChIP peaks. Traditional Foxp3, H3K27ac, H3K4me3, and H2K27me3 ChIP-seq data are from Kitagawa et al. (2017). (E) Comparison of accessible chromatin regions (ATAC-seq peaks) in iTreg and nTreg cells. (F) Comparison of the peak sizes of Foxp3 PSI-ChIP, traditional Foxp3-ChIP, H3K27ac-ChIP, and ATAC-seq. Numbers show mean fragment lengths. Data were derived from two replicates. (G) PCA of Foxp3 PSI and histone H3 PSI TMT MS results. PC1 and PC2, respectively, account for 48.9% and 27.7% of the total variations. AU, arbitrary units. (H) Fractions of proteins identified by Foxp3 or H3 PSI MS among the genes expressed in ASC-treated iTreg cells, estimated by RNA-seq (RPKM ≥ 1.0). (I) Enriched proteins identified by Foxp3-PSI in iTreg versus Th0 cells and Foxp3-PSI versus H3-PSI in iTreg cells. Blue, Foxp3 known interactors. q, FDR-adjusted P value. Histone H3 PSI was used to assess the diffusion of BP radicals. Data were derived from two replicates. (J) Comparison of proteins revealed by Foxp3-PSI versus H3-PSI MS and published Foxp3 interactors (Rudra et al., 2012).

or Create an Account

Close Modal
Close Modal